These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19641652)

  • 1. Sarcolemmal fragility secondary to the degradation of dystrophin in dilated cardiomyopathy, as estimated by electron microscopy.
    Kawada T; Hemmi C; Fukuda S; Tezuka A; Iwasawa K; Nakazawa M; Sato H; Toyo-Oka T
    Exp Clin Cardiol; 2003; 8(2):67-70. PubMed ID: 19641652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy prevents disruption of dystrophin-related proteins in a model of hereditary dilated cardiomyopathy in hamsters.
    Toyo-oka T; Kawada T; Xi H; Nakazawa M; Masui F; Hemmi C; Nakata J; Tezuka A; Iwasawa K; Urabe M; Monahan J; Ozawa K
    Heart Lung Circ; 2002; 11(3):174-81. PubMed ID: 16352094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new paradigm for the progression of advanced heart failure].
    Kawada T; Nakazawa M; Toyo-oka T
    Nihon Yakurigaku Zasshi; 2004 Feb; 123(2):55-62. PubMed ID: 14745124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex.
    Sakamoto A; Ono K; Abe M; Jasmin G; Eki T; Murakami Y; Masaki T; Toyo-oka T; Hanaoka F
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13873-8. PubMed ID: 9391120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Somatic gene therapy of dilated cardiomyopathy].
    Kawada T; Nakazawa M; Toyo-Oka T
    Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):37-44. PubMed ID: 11862755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters.
    Kawada T; Nakazawa M; Nakauchi S; Yamazaki K; Shimamoto R; Urabe M; Nakata J; Hemmi C; Masui F; Nakajima T; Suzuki J; Monahan J; Sato H; Masaki T; Ozawa K; Toyo-Oka T
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):901-6. PubMed ID: 11805334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamster.
    Straub V; Duclos F; Venzke DP; Lee JC; Cutshall S; Leveille CJ; Campbell KP
    Am J Pathol; 1998 Nov; 153(5):1623-30. PubMed ID: 9811355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel scheme of dystrophin disruption for the progression of advanced heart failure.
    Kawada T; Masui F; Tezuka A; Ebisawa T; Kumagai H; Nakazawa M; Toyo-Oka T
    Biochim Biophys Acta; 2005 Aug; 1751(1):73-81. PubMed ID: 16054019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered membrane proteins and permeability correlate with cardiac dysfunction in cardiomyopathic hamsters.
    Ikeda Y; Martone M; Gu Y; Hoshijima M; Thor A; Oh SS; Peterson KL; Ross J
    Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1362-70. PubMed ID: 10749734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy.
    Lee GH; Badorff C; Knowlton KU
    Circ Res; 2000 Sep; 87(6):489-95. PubMed ID: 10988241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced sarcolemmal dystrophin distribution and upregulation of utrophin in the cardiac and skeletal muscles of CHF-146 dystrophic hamsters.
    Bhattacharya SK; Johnson PL; Li HJ; Handa RK; Adamec TA
    Mol Chem Neuropathol; 1997 Jun; 31(2):187-206. PubMed ID: 9376024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: a scheme for the progression of cardiac dysfunction.
    Toyo-Oka T; Kawada T; Nakata J; Xie H; Urabe M; Masui F; Ebisawa T; Tezuka A; Iwasawa K; Nakajima T; Uehara Y; Kumagai H; Kostin S; Schaper J; Nakazawa M; Ozawa K
    Proc Natl Acad Sci U S A; 2004 May; 101(19):7381-5. PubMed ID: 15128945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer.
    Holt KH; Lim LE; Straub V; Venzke DP; Duclos F; Anderson RD; Davidson BL; Campbell KP
    Mol Cell; 1998 May; 1(6):841-8. PubMed ID: 9660967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the delta-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2).
    Duggan DJ; Manchester D; Stears KP; Mathews DJ; Hart C; Hoffman EP
    Neurogenetics; 1997 May; 1(1):49-58. PubMed ID: 10735275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.
    Badorff C; Knowlton KU
    Med Microbiol Immunol; 2004 May; 193(2-3):121-6. PubMed ID: 12920582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrobrevin increases dystrophin's binding to the dystrophin-glycoprotein complex and provides protection during cardiac stress.
    Strakova J; Dean JD; Sharpe KM; Meyers TA; Odom GL; Townsend D
    J Mol Cell Cardiol; 2014 Nov; 76():106-15. PubMed ID: 25158611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic loss of sarcolemmal dystrophin and spectrin: correlation with myocardial injury.
    Armstrong SC; Latham CA; Shivell CL; Ganote CE
    J Mol Cell Cardiol; 2001 Jun; 33(6):1165-79. PubMed ID: 11444921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetics of dilated cardiomyopathy].
    Osterziel KJ; Scheffold T; Perrot A; Dietz R;
    Z Kardiol; 2001 Jul; 90(7):461-9. PubMed ID: 11515275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological and physiological restorations of hereditary form of dilated cardiomyopathy by somatic gene therapy.
    Kawada T; Sakamoto A; Nakazawa M; Urabe M; Masuda F; Hemmi C; Wang Y; Shin WS; Nakatsuru Y; Sato H; Ozawa K; Toyo-oka T
    Biochem Biophys Res Commun; 2001 Jun; 284(2):431-5. PubMed ID: 11394897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice.
    Porter JD; Merriam AP; Hack AA; Andrade FH; McNally EM
    Neuromuscul Disord; 2001 Mar; 11(2):197-207. PubMed ID: 11257478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.